Cytokinetics: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Thursday reported a loss of $128.6 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.34.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.23 per share.
The biopharmaceutical company posted revenue of $867,000 in the period, which also did not meet Street forecasts. Eight analysts surveyed by Zacks expected $2.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK
